Prof. Dr. Ender Kurt

Avci N, Deligonul A, Tolunay S, Cubukcu E, Fatih Olmez O, Altmisdortoglu O, Tanriverdi O, Aksoy A, Kurt E, Evrensel T. Prognostic impact of tumor lymphocytic infiltrates in patients with breast cancer undergoing neoadjuvant chemotherapy. J BUON. 2015 Jul-Aug;20(4):994-1000. PMID: 26416041.

Olmez OF, Cubukcu E, Evrensel T, Kanat O, Kurt E, Akyıldız EU, Coskun BN, Manavoglu O. Pulmonary actinomycosis mimicking metastasis from lung adenocarcinoma. Onkologie. 2012;35(10):604-6. doi: 10.1159/000342675. Epub 2012 Sep 18. PMID: 23038234.

Arslan M, Evrensel T, Kurt E, Demiray M, Gonullu G, Kanat O, Manavoglu O. Comparison of clinical outcomes of different erythropoietin usage strategies. Tumori. 2004 Jul-Aug;90(4):394-8. doi: 10.1177/030089160409000406. PMID: 15510982.

Kurt E, Cubukcu E, Karabulut B, Olmez OF, Kurt M, Avci N, Ozdemir F, Tunali D, Evrensel T, Manavoglu O. A multi-institutional evaluation of carboplatin plus docetaxel regimen in elderly patients with advanced gastric cancer. J BUON. 2013 Jan-Mar;18(1):147-53. PMID: 23613400.

Kanat O, Adim S, Evrensel T, Yerci O, Ediz B, Kurt E, Demiray M, Gonullu G, Arslan M, Manavoglu O. Prognostic value of nm23 in gastrointestinal stromal tumors. Med Oncol. 2004;21(1):53-8. doi: 10.1385/MO:21:1:53. PMID: 15034214.

Sag SO, Gorukmez O, Ture M, Gorukmez O, Deligonul A, Sahinturk S, Topak A, Gulten T, Kurt E, Yakut T. Spectrum of EGFR gene mutations and ALK rearrangements in lung cancer patients in Turkey. Springerplus. 2016 Apr 19;5:482. doi: 10.1186/s40064-016-2150-4. eCollection 2016. PMID: 27217997.

Kanat O, Evrensel T, Manavoglu O, Demiray M, Kurt E, Gonullu G, Kiyici M, Arslan M. Single-agent irinotecan as second-line treatment for advanced gastric cancer. Tumori. 2003 Jul-Aug;89(4):405-7. doi: 10.1177/030089160308900411. PMID: 14606644.

Kanat O, Yalcinkaya U, Akbunar T, Kurt E, Evrensel T, Manavoglu O. Gemcitabine plus paclitaxel may be a promising chemotherapy regimen for metastatic granular cell tumour. Clin Oncol (R Coll Radiol). 2008 Feb;20(1):93-6. doi: 10.1016/j.clon.2007.09.002. Epub 2007 Oct 22. PMID: 17936602.

Kurt E, Filiz G, Vuruskan H, Kurt M, Evrensel T. Life-threatening complications of an extremely rare tumor of the kidney: adult-type primary renal ganglioneuroblastoma. South Med J. 2007 Aug;100(8):852-3. doi: 10.1097/SMJ.0b013e318063c4ea. PMID: 17713319.

Ozkalemkas F, Ali R, Ozkocaman V, Ozcelik T, Ozan U, Ozturk H, Kurt E, Evrensel T, Yerci O, Tunali A. The bone marrow aspirate and biopsy in the diagnosis of unsuspected nonhematologic malignancy: a clinical study of 19 cases. BMC Cancer. 2005 Nov 1;5:144. doi: 10.1186/1471-2407-5-144. PMID: 16262899.

Cubukcu E, Fatih Olmez O, Saraydaroglu O, Akcali U, Kanat O, Kurt E, Evrensel T, Manavoglu O. Immunohistochemical expression of excision repair cross-complementing 1 (ERCC1) in non-small-cell lung cancer: implications for patient outcome. Clin Transl Oncol. 2011 Nov;13(11):826-30. doi: 10.1007/s12094-011-0741-7. PMID: 22082649.

Bayrak M, Olmez OF, Kurt E, Cubukcu E, Evrensel T, Kanat O, Manavoglu O. Prognostic significance of c-erbB2 overexpression in patients with metastatic gastric cancer. Clin Transl Oncol. 2013 Apr;15(4):307-12. doi: 10.1007/s12094-012-0921-0. Epub 2012 Aug 22. PMID: 22911549.

Olmez OF, Evrensel T, Cubukcu E, Ugras N, Avci N, Canhoroz M, Deligonul A, Hartavi M, Olmez F, Cubukcu S, Tolunay S, Kurt E, Kanat O, Manavoglu O. Prognostic significance of human epidermal receptor (HER)- 3 immunohistochemical expression in patients with metastatic breast cancer. Asian Pac J Cancer Prev. 2013;14(7):4115-9. doi: 10.7314/apjcp.2013.14.7.4115. PMID: 23991962.

Cubukcu E, Olmez OF, Avci N, Canhoroz M, Kurt E, Kanat O, Evrensel T, Manavoglu O. Identification of prognostic factors in patients with metastatic gastrointestinal stromal tumors. J BUON. 2012 Jul-Sep;17(3):517-21. PMID: 23033292.

Avcı N, Ture M, Deligonul A, Cubukcu E, Olmez OF, Sahinturk S, Topak A, Kurt E, Evrensel T, Şahin AB, Yakut T. Association and Prognostic Significance of the Functional -1562C/T Polymorphism in the Promoter Region of MMP-9 in Turkish Patients with Gastric Cancer. Pathol Oncol Res. 2015 Sep;21(4):1243-7. doi: 10.1007/s12253-015-9950-7. Epub 2015 Jul 9. PMID: 26156886.

Ozkan K, Turkkan E, Ender K, Mutlu D, Murat A, Nalan B, Abdulmecit Y, Osman M. 5-Fluorouracil, epirubicin and cisplatin in the treatment of metastatic gastric carcinoma: a retrospective analysis of 68 patients. Indian J Cancer. 2005 Apr-Jun;42(2):85-8. doi: 10.4103/0019-509x.16697. PMID: 16141507.

Demiray M, Gulten M, Manavoglu O, Evrensel T, Ulukaya E, Yerci O, Kanat O, Kurt E, Arslan M, Gonullu G, Demiray H, Gulten T, Memik F. Evaluation of the effects of Helicobacter pylori eradication therapy on gastric antral epithelial hyperproliferation: a prospective six-month follow-up study. Hepatogastroenterology. 2004 Sep-Oct;51(59):1531-5. PMID: 15362794.

Orhan B, Yalçin S, Evrensel T, Kurt E, Manavoğlu O, Erbaş T. Does cisplatin stimulate erythropoietin secretion from the peritubular cells of the kidney? Clin Nephrol. 1998 Sep;50(3):202-3. PMID: 9776431.

Kurt E, Kurt M, Kanat O, Cetintas SK, Aygun S, Palazoglu T, Ozkan L, Evrensel T, Kaya E, Manavoglu O. Phase II study of induction chemotherapy with gemcitabine plus 5-fluorouracil followed by gemcitabine-based concurrent chemoradiotherapy for unresectable locally advanced pancreatic cancer. Tumori. 2006 Nov-Dec;92(6):481-6. doi: 10.1177/030089160609200603. PMID: 17260487.

Orhan B, Manavoğlu O, Evrensel T, Kurt E. Cervical spine involvement in metastatic colorectal carcinomas: should we think about an alternative route of metastasis other than Batson's plexus? Clin Oncol (R Coll Radiol). 1999;11(1):65-6. doi: 10.1053/clon.1999.9014. PMID: 10194592.

Avci N, Cecener G, Deligonul A, Erturk E, Tunca B, Egeli U, Tezcan G, Akyildiz EU, Bayram AS, Gebitekin C, Kurt E, Evrensel T. Molecular markers for patients with thymic malignancies: not feasible at present? Asian Pac J Cancer Prev. 2014;15(8):3457-60. doi: 10.7314/apjcp.2014.15.8.3457. PMID: 24870739.

Kanat O, Baskan BE, Kurt E, Evrensel T. Successful treatment of palmar-plantar erythrodysesthesia possibly due to temozolomide with dexamethasone. J Postgrad Med. 2007 Apr-Jun;53(2):146. doi: 10.4103/0022-3859.32222. PMID: 17495388.

Kanat O, Evrensel T, Adim SB, Yavascaoglu I, Kurt E, Demiray M, Gonullu G, Manavoglu O. Small cell carcinoma of the urinary bladder. A clinicopathologic study of five cases. Tumori. 2003 May-Jun;89(3):328-30. doi: 10.1177/030089160308900319. PMID: 12908793.

Kurt E, Sezgin C, Evrensel T, Yalcinkaya U, Kanat O, Veral A, Demiray M, Arslan M, Karabulut B, Ercan I, Goker E, Manavoglu O. Therapy, outcome and analysis of c-kit expression in patients with extrapulmonary small cell carcinoma. Int J Clin Pract. 2005 May;59(5):537-43. doi: 10.1111/j.1368-5031.2005.00447.x. PMID: 15857349.

Kurt M, Ozkan L, Kurt E, Cetintas SK, Aygun S, Ercan I, Yilmazlar T, Memik F. Comparison of protracted infusion 5-fluorouracil and capecitabine in adjuvant chemoradiotherapy for rectal cancer. Hepatogastroenterology. 2008 Jul-Aug;55(85):1158-63. PMID: 18795649.

Ersoy A, Yavuz M, Usta M, Ercan I, Aslanhan I, Güllülü M, Kurt E, Emir G, Dilek K, Yurtkuran M. Survival analysis of the factors affecting in mortality in injured patients requiring dialysis due to acute renal failure during the Marmara earthquake: survivors vs non-survivors. Clin Nephrol. 2003 May;59(5):334-40. doi: 10.5414/cnp59334. PMID: 12779094.

Demiray M, Kurt E, Evrensel T, Kanat O, Arslan M, Saraydaroglu O, Ercan I, Gonullu G, Gokgoz S, Topal U, Tolunay S, Tasdelen I, Manavoglu O. Phase II study of gemcitabine plus paclitaxel in metastatic breast cancer patients with prior anthracycline exposure. Cancer Invest. 2005;23(5):386-91. doi: 10.1081/cnv-67133. PMID: 16193637.

Deligonul A, Evrensel T, Avci N, Ugras N, Ture M, Cubukcu E, Hartavi M, Fatih Olmez O, Kurt E, Tolunay S, Kanat O, Manavoglu O. Immunohistochemical expression of human epidermal growth factor receptor (HER)-4 and prognosis in patients with metastatic breast cancer. J BUON. 2016 May-Jun;21(3):564-9. PMID: 27569073.

Gonullu G, Ersoy C, Ersoy A, Evrensel T, Basturk B, Kurt E, Oral B, Gokgoz S, Manavoglu O. Relation between insulin resistance and serum concentrations of IL-6 and TNF-alpha in overweight or obese women with early stage breast cancer. Cytokine. 2005 Aug 21;31(4):264-9. doi: 10.1016/j.cyto.2005.05.003. PMID: 15955709.

Avci N, Deligonul A, Tolunay S, Cubukcu E, Fatih Olmez O, Ulas A, Hartavi M, Kurt E, Evrensel T. Neoadjuvant chemotherapy-induced changes in immunohistochemical expression of estrogen receptor, progesterone receptor, HER2, and Ki-67 in patients with breast cancer. J BUON. 2015 Jan-Feb;20(1):45-9. PMID: 25778295.

Kanat O, Evrensel T, Baran I, Coskun H, Zarifoglu M, Turan OF, Kurt E, Demiray M, Gonullu G, Manavoglu O. Protective effect of amifostine against toxicity of paclitaxel and carboplatin in non-small cell lung cancer: a single center randomized study. Med Oncol. 2003;20(3):237-45. doi: 10.1385/MO:20:3:237. PMID: 14514973.

Kurt E, Manavoglu O, Dilek K, Orhan B, Evrensel T. Effect of cisplatin on plasma renin activity and serum aldosterone levels. Clin Nephrol. 1999 Dec;52(6):397-8. PMID: 10604651.

Cubukcu E, Kanat O, Fatih Olmez O, Kabul S, Canhoroz M, Avci N, Deligonul A, Hartavi M, Cubukcu S, Olmez F, Kurt E, Evrensel T, Gokgoz S, Manavoglu O. Prognostic significance of estrogen receptor, progesterone receptor, HER2/neu, Ki-67, and nm23 expression in patients with invasive breast cancer. J BUON. 2013 Apr-Jun;18(2):359-65. PMID: 23818346.

Kanat O, Kurt E, Yalcinkaya U, Evrensel T, Manavoglu O. Comparison of uroprotective efficacy of mesna and amifostine in Cyclophosphamide- induced hemorrhagic cystitis in rats. Indian J Cancer. 2006 Jan-Mar;43(1):12-5. doi: 10.4103/0019-509x.25769. PMID: 16763356.

Kanat O, Evrensel T, Kurt E, Arslan M, Demiray M, Aker S, Manavoglu O. Successful treatment of thymoma-associated erythroid hypoplasia and thrombocytopenia with paclitaxel. Clin Oncol (R Coll Radiol). 2005 Feb;17(1):68. doi: 10.1016/j.clon.2004.10.001. PMID: 15714934.

Arslan M, Evrensel T, Kurt E, Demiray M, Ercan I, Kanat O, Ozkan A, Manavoglu O. Comparison of the serum erythropoietin levels in chemotherapy-naive and cisplatin-treated cancer patients. Neoplasma. 2005;52(1):43-5. PMID: 15739025.

Gulten T, Evke E, Ercan I, Evrensel T, Kurt E, Manavoglu O. Lack of genotoxicity in medical oncology nurses handling antineoplastic drugs: effect of work environment and protective equipment. Work. 2011;39(4):485-9. doi: 10.3233/WOR-2011-1198. PMID: 21811037.

Kanat O, Evrensel T, Demiray M, Kurt E, Gonullu G, Arslan M, Manavoglu O, Ozkan A. Cisplatin plus etoposide in advanced non-small cell lung cancer patients age of 70 years or older. Lung Cancer. 2003 Aug;41(2):233-4. doi: 10.1016/s0169-5002(03)00199-5. PMID: 12871788.

Hartavi M, Kurt E, Oral B, Olmez OF, Cubukcu E, Deligonul A, Avci N, Manavoglu O. The SOCS-1 -1478CA/del polymorphism is not associated with colorectal cancer or age at onset in Turkish subjects. Asian Pac J Cancer Prev. 2013;14(12):7583-6. doi: 10.7314/apjcp.2013.14.12.7583. PMID: 24460337.

Kanat O, Evrensel T, Kurt E, Keskin K, Akcali U, Manavoglu O. Fatal ischemic bowel necrosis possibly due to docetaxel and cisplatin in a patient with non-small cell lung cancer. Lung Cancer. 2007 Apr;56(1):143-4. doi: 10.1016/j.lungcan.2007.01.005. Epub 2007 Feb 8. PMID: 17291625.

Kanat O, Evrensel T, Kurt E, Demiray M, Gonullu G, Arslan M, Manavoglu O. Treatment of metastatic pancreatic cancer with a combination of gemcitabine and 5-fluorouracil: a single center phase II study. Tumori. 2004 Mar-Apr;90(2):192-5. doi: 10.1177/030089160409000206. PMID: 15237581.

Sezgin C, Kurt E, Evrensel T, Ozdemir N, Manavoglu O, Goker E. Efficacy of lower dose capecitabine in patients with metastatic breast cancer and factors influencing therapeutic response and outcome. South Med J. 2007 Jan;100(1):27-32. doi: 10.1097/01.smj.0000252968.87824.19. PMID: 17269522.

Doğan G, Kurt E. Effects of Chemotherapy and Chemoradiotherapy on Survival and Toxicity in Locally Advanced Unresectable Pancreatic Cancer. Journal of Uludağ University Medical Faculty. 2026;52. DOI: 10.32708/uutfd.1927390.

Gökçen P, Kurt E. Factors that affect survival in low grade gliomas and the prognostic significance of the Ki-67 proliferation index. Cumhuriyet Medical Journal. 2020;42(3):301–310. DOI: 10.7197/cmj.vi.742816.

Kurt E, Evrensel T, Gönüllü G, Kanat Ö, Demiray M, Arslan M, Ünlü Ö, Dilek K, Manavoğlu O. Cisplatin’e Bağlı Böbrek Toksisitesi ve Sentetik Oral Prostaglandin E1 Analoğunun Etkinliğinin Değerlendirilmesi. Uludağ Üniversitesi Tıp Fakültesi Dergisi. 2002;28(2):17–20.